Clinical Research Directory

Inclusion Criteria: 1. Physician-confirmed clinical diagnosis of asthma according to GINA guidelines 2. Uncontrolled asthma according to the physician's clinical assessment despite the use of appropriate therapy of Step 2 or 3, according to GINA guidelines 3. Patients who are eligible for the use of Foster Nexthaler 100/6 mcg according to the SmPC 4. Inhaled asthma therapy was changed independent from the study to Foster Nexthaler 100/6 mcg DPI maximum 1 week prior to OR on the day of study inclusion 5. Spirometry was performed as part of routine clinical practice 6. Patient able to use their Foster Nexthaler device properly after education on inhaler technique 7. Patient provided written, informed consent to study participation 8. Patient ≥ 18 years of age Exclusion Criteria: 1. Participation in any clinical trial, 30 days prior to inclusion 2. Patient is unable to execute a spirometry test 3. Patients hospitalized due to an exacerbation of their asthma within the last 4 weeks prior to enrolment. 4. Patients with other significant diseases of the respiratory system or other organ systems that may significantly contribute to asthma symptoms (such as severe heart failure, symptomatic anaemia, functional respiratory disorders, malignant diseases etc.) according to the physician's clinical assessment. 5. Continuous use of oral corticosteroids (\>5 mg prednisolone/day or \>4 mg methylprednisolone/day) 6. Use of continuous oxygen therapy 7. Use of biologics for asthma treatment 8. All exclusion criteria listed in Foster Nexthaler 100/6 SmPC